Letteratura scientifica selezionata sul tema "Maladies ovariennes"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Maladies ovariennes".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Maladies ovariennes":
Pierucci, A. F., F. Pessione, C. Deneux-Tharaux, G. Plu-Bureau e V. Olié. "Maladie veineuse thrombo-embolique et stimulation ovarienne, 2012–2014, France". Revue d'Épidémiologie et de Santé Publique 64 (marzo 2016): S9. http://dx.doi.org/10.1016/j.respe.2016.01.035.
Massin, N., A. Bachelot, G. Méduri, C. Matuchanski, K. Laborde, J. Guibourdenche, A. Gougeon et al. "P097 - Insuffisance ovarienne prématurée (IOP) : description d’un réseau clinique, biologique et génétique pour son analyse physiopathologique (GIS maladies rares)". Annales d'Endocrinologie 66, n. 5 (ottobre 2005): 443. http://dx.doi.org/10.1016/s0003-4266(05)81938-9.
Lhote, F., C. Mainguéné, B. Jarrousse, J. Amouroux e L. Guillevin. "Artérite à cellules géantes ovarienne révélatrice d'une maladie de Horton. A propos d'un cas avec revue de la littérature". La Revue de Médecine Interne 12, n. 6 (novembre 1991): S461. http://dx.doi.org/10.1016/s0248-8663(05)80805-7.
Hyon, Capucine, Virginie Grouthier, Patricia Dournaux, Isabelle Pinson, Sylvie Lucchini e Jean-Pierre Siffroi. "Inversion péricentrique d’un chromosome 7 associée à une insuffisance ovarienne prématurée et une maladie inflammatoire chronique de l’intestin : 2 points de cassure pour 2 symptômes ?" Morphologie 100, n. 330 (settembre 2016): 162. http://dx.doi.org/10.1016/j.morpho.2016.07.006.
Tesi sul tema "Maladies ovariennes":
Nieuwjaer, Laurine. "Développement d'un dispositif d'illumination pour le traitement de la carcinose péritonéale d'origine ovarienne par thérapie photodynamique intracavitaire". Electronic Thesis or Diss., Université de Lille (2022-....), 2023. http://www.theses.fr/2023ULILS044.
Ovarian cancer represents the 5th leading cause of death by cancer in women in France, with more than 3935 deaths in 2020. Its evolution is characterized by the invasion of all or part of the peritoneum by ovarian metastases defining the notion of peritoneal carcinomatosis of ovarian origin.The standard treatment for ovarian peritoneal carcinomatosis consists of cytoreduction surgery, the objective of which is to remove the tumors visible to the eye of the surgeon, associated with chemotherapy. However, the recurrence rate, linked to the presence of residual tumours, is high and occurs in two thirds of cases. In case of recurrence, the prognosis is poor with a median survival not exceeding a few months.Studies have shown that the presence of visible or even microscopic residual tumors following surgery significantly increases the risk of recurrence. Thus, a treatment enabling the destruction all persistent tumors within the peritoneal cavity after surgery would therefore reduce or even prevent recurrences and thus increase the overall survival of patients.In this context, we propose to use photodynamic therapy (PDT) as an adjuvant treatment. Indeed, PDT consists of the administration of a photosensitizer (PS), which after accumulating preferentially in tumor cells, is activated by illumination at a specific wavelength. This activation leads to the generation of cytotoxic molecules responsible for the death of tumor cells and constitutes the first direct effect of PDT. The 2nd and 3rd effects of PDT, this time indirect, consist of hypoxia of the tumor caused by the alteration of its vascularization and activation of the antitumor immune system.Through its strong expertise in the use of PDT against several types of cancers and precancers, the ONCOTHAI laboratory initiated the PRODYNOV project, aimed at bringing together the conditions necessary for the development of clinical PDT for peritoneal carcinomatosis of origin ovarian. As part of this project, a PS specifically targeting cancer cells of ovarian origin was developed and patented in 2017.The main objective of thesis is part of this innovative project and consists of the development of a light emitting device that will be installed during surgery, within the peritoneal cavity, and will allow the activation of the PS in order to eliminate all residual tumors. This luminous device was developed and tested on an innovative measuring bench prototype, also developed during this research work.In addition to these developments, a study of the effect of the operating lamp, systematically present above the patient's body during surgery, was also carried out. Indeed, as the PS is administered to the patient several hours before the beginning of the surgery, the light delivered by the operating lamp can generate a PDT effect that must be considered.The light emitting device developed as well as the operating lamp are currently the subject of a preclinical study on pig. This study aims to demonstrate the feasibility of optimal intracavitary illumination. Dosimetry of the illumination will then be carried out on the living model in order to ensure the delivered light doses.In parallel with these advances, we have developed in vitro and in vivo illumination devices which have enabled to validate the effectiveness of the new PS on human cell lines of ovarian cancer and on humanized mouse models of peritoneal carcinomatosis of ovarian origin.In conclusion, this thesis allowed to initiate the positioning of PDT in the management of peritoneal carcinomatosis of ovarian origin as an adjuvant treatment
Monneret, Brigitte. "Les stérilités d'origine ovarienne : explorations et perspectives d'avenir". Paris 5, 1989. http://www.theses.fr/1989PA05P174.
Marandais, Papon Véronique de la. "Kystes ovariens du nouveau-né : diagnostic anté-natal et conduite à tenir : à propos de 4 cas". Nantes, 1985. http://www.theses.fr/1985NANT3349.
Abdelmoumen, Mehdi. "Transposition ovarienne au cours de la maladie de Hodgkin : techniques, indications, résultats, à propos de 24 cas d'inventaire abdominal". Montpellier 1, 1990. http://www.theses.fr/1990MON11029.
Lis, Raphaël. "Implication du microenvironnement sur la survenue de la maladie métastatique et l'apparition d'une maladie résiduelle dans les adénocarcinomes ovariens séreux". Phd thesis, Université Paris Sud - Paris XI, 2011. http://tel.archives-ouvertes.fr/tel-00753251.
Lis, Raphaêl. "Implication du microenvironnement sur la survenue de la maladie métastatique et l’apparition d’une maladie résiduelle dans les adénocarcinomes ovariens séreux". Thesis, Paris 11, 2011. http://www.theses.fr/2011PA11T079/document.
Ovarian cancers constitute a poor prognosis disease. Due to their absence of symptoms, ovarian cancers are generally diagnosed at late stages. Despite major breakthrough regarding ovarian cancer surgery, minimal residual disease-induced relapse is still a hurdle for clinicians.Tumor microenvironment is a key actor on disease progression and resistance to therapy. In this study, we have focused on two major components of the tumor stroma, on one hand, the mesenchymal stem cells, and the endothelial cells on the other hand.We were able to demonstrate that mesenchymal stem cells are critically involved in ovarian cancer progression and resistance to therapy, while the endothelium, through production of angiocrine factors, is deeply involved in resistance of ovarian cancer cells to platinum and taxane based therapy.Here, we set forth the idea that disrupting the relationship between ovarian cancer cells and their host stroma constitute a new therapeutic window
Vinoy, Sophie. "Etude du rôle du bilan énergétique et de la composition de l'alimentation sur la régulation de la fonction ovarienne chez la femme allaitante au Bangladesh". Paris 5, 1999. http://www.theses.fr/1999PA05CD18.
Hyon, Capucine. "Étude des gènes impliqués dans le déterminisme gonadique chez l'homme". Electronic Thesis or Diss., Paris 6, 2016. https://accesdistant.sorbonne-universite.fr/login?url=https://theses-intra.sorbonne-universite.fr/2016PA066493.pdf.
Disorders of Sex Development (DSD) can be identified in new-born and during infancy but also in adults because of infertility. Most 46,XX testicular DSD have a normal testicular development due to the presence of the SRY gene at the tip of one of their X chromosome. However, the genetic causes of 46,XX-SRY negative testicular DSD remain poorly defined. In women, disorders of gonadal development can be responsible for primary ovarian insufficiency (POI) and genetic causes are identify in only 20% of cases. The aim of this thesis was to identify molecular mechanisms involved in gonadal development and in its functioning. The cohort study of 46,XX testicular DSD identified four patients with a duplication in the previously reported RevSex region located about 550 kb upstream of SOX9. One duplication allowed us to refine the minimal region associated with 46,XX-SRY negative DSD to a 40.7–41.9 kb element. Exome sequencing of 10 patients from the cohort did not show any mutation in genes implicated in DSD or in new candidate genes. These results raise questions about the role of the regulatory sequences in the onset of DSD.The cohort study of POI patients identified three patients carrying a microdeletion including CPEB1 a good candidate gene for POI as study in mice showed the implication of CPEB1 in follicular development. Sequencing CPEB1 gene did not identified any mutation. Therefore, heterozygous deletion of CPEB1 gene leading to haploinsufficiency could be responsible for POI in humans. This microdeletion is rare but recurrent and was identified in about 1% of patients with POI. Another microdeletion containing CASP3 gene that belongs to the caspase family, which is implicated in the regulation of the follicular pool, was identified in a patient. Further studies are needed to confirm the role of CASP3 in POI. These results demonstrate the importance of genetic study of patients presenting with DSD or POI using whole genome techniques
Hyon, Capucine. "Etude des gènes impliqués dans le déterminisme gonadique chez l'homme". Thesis, Paris 6, 2016. http://www.theses.fr/2016PA066493/document.
Disorders of Sex Development (DSD) can be identified in new-born and during infancy but also in adults because of infertility. Most 46,XX testicular DSD have a normal testicular development due to the presence of the SRY gene at the tip of one of their X chromosome. However, the genetic causes of 46,XX-SRY negative testicular DSD remain poorly defined. In women, disorders of gonadal development can be responsible for primary ovarian insufficiency (POI) and genetic causes are identify in only 20% of cases. The aim of this thesis was to identify molecular mechanisms involved in gonadal development and in its functioning. The cohort study of 46,XX testicular DSD identified four patients with a duplication in the previously reported RevSex region located about 550 kb upstream of SOX9. One duplication allowed us to refine the minimal region associated with 46,XX-SRY negative DSD to a 40.7–41.9 kb element. Exome sequencing of 10 patients from the cohort did not show any mutation in genes implicated in DSD or in new candidate genes. These results raise questions about the role of the regulatory sequences in the onset of DSD.The cohort study of POI patients identified three patients carrying a microdeletion including CPEB1 a good candidate gene for POI as study in mice showed the implication of CPEB1 in follicular development. Sequencing CPEB1 gene did not identified any mutation. Therefore, heterozygous deletion of CPEB1 gene leading to haploinsufficiency could be responsible for POI in humans. This microdeletion is rare but recurrent and was identified in about 1% of patients with POI. Another microdeletion containing CASP3 gene that belongs to the caspase family, which is implicated in the regulation of the follicular pool, was identified in a patient. Further studies are needed to confirm the role of CASP3 in POI. These results demonstrate the importance of genetic study of patients presenting with DSD or POI using whole genome techniques